Drug level in human hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/S...

Basic Information

ID: ALA3528818

Type: ADME

Description: Drug level in human hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM

Format: BAO_0000219

Organism: Homo sapiens

Cell type: Hepatocyte

Target: Hepatocyte(ALA613690)

Document: ALA3526048

Drug level in human hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/SAM: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA3528818

Drug metabolism

Total(2)

Parent Molecular Weight	ALogP	Polar Surface Area
591.60	0.49	0.49
573.58	0.66	0.66

Parent Molecular Weight

ALogP

Polar Surface Area

591.60

0.49

573.58

0.66

Drug level in human hepatocytes treated with [14C]-rivoglitazone at 30 uM after 3 hrs by radio-HPLC/LC-MS/MS analysis in presence of UDPGA and UDPGA/S...

Basic Information

Activity Charts

Compound Summary